Zhejiang Anglikang Pharmaceutical Co Ltd Class A (002940) — Capital Reinvestment Ratio
Zhejiang Anglikang Pharmaceutical Co Ltd Class A (002940) has a Capital Reinvestment Ratio of 0.15x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥112.57 Million) in capital expenditures (CN¥16.66 Million). See 002940 equity to assets ratio to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Zhejiang Anglikang Pharmaceutical Co Ltd Class A Capital Reinvestment Ratio (2014–2025)
This chart tracks Zhejiang Anglikang Pharmaceutical Co Ltd Class A's Capital Reinvestment Ratio across 12 annual periods. Check Zhejiang Anglikang Pharmaceutical Co Ltd cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Zhejiang Anglikang Pharmaceutical Co Ltd Class A (2014–2025)
Year-by-year Capital Reinvestment Ratio for Zhejiang Anglikang Pharmaceutical Co Ltd Class A from 2014 to 2025. For live market cap and broader valuation context, see Zhejiang Anglikang Pharmaceutical Co Ltd market cap and net worth.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.20x | CN¥244.13 Million | CN¥49.94 Million | ▼ -45.1% |
| 2024 | 0.37x | CN¥253.60 Million | CN¥94.46 Million | ▼ -17.5% |
| 2023 | 0.45x | CN¥276.91 Million | CN¥124.95 Million | ▲ +21.1% |
| 2022 | 0.37x | CN¥184.75 Million | CN¥68.82 Million | ▼ -15.7% |
| 2021 | 0.44x | CN¥197.65 Million | CN¥87.32 Million | ▼ -3.5% |
| 2020 | 0.46x | CN¥198.61 Million | CN¥90.96 Million | ▲ +29.4% |
| 2019 | 0.35x | CN¥213.49 Million | CN¥75.58 Million | ▼ -30.6% |
| 2018 | 0.51x | CN¥133.61 Million | CN¥68.17 Million | ▲ +80.5% |
| 2017 | 0.28x | CN¥193.77 Million | CN¥54.79 Million | ▲ +55.3% |
| 2016 | 0.18x | CN¥141.74 Million | CN¥25.81 Million | ▼ -28.1% |
| 2015 | 0.25x | CN¥138.59 Million | CN¥35.10 Million | ▼ -73.6% |
| 2014 | 0.96x | CN¥50.46 Million | CN¥48.48 Million | — |